Randomised Controlled Trial on 360° Phototherapy versus Single Surface LED Phototherapy in Neonatal Hyperbilirubinemia
Not Applicable
Completed
- Conditions
- eonatal hyperbilirubinemiaNeonatal hyperbilirubinemiaReproductive Health and Childbirth - Complications of newborn
- Registration Number
- ACTRN12624000590561
- Lead Sponsor
- niversiti Sains Malaysia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
The study will include all term neonates who are born at 35 weeks of age or more, and age less than or equal to 7 days, with unconjugated hyperbilirubinemia, requiring intensive phototherapy following the Malaysian guideline of neonatal jaundice. The neonates weight must be 2 kg or more and has not received any phototherapy before.
Exclusion Criteria
Neonates whose serum bilirubin level is above the exchange transfusion level following the Malaysian guideline of neonatal jaundice will not be included in the study. Other exclusion criterias include direct hyperbilirubinemia of >15%, neonates with congenital abnormalities or inborn error of metabolism and neonates who required intensive care.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method